Demand for an Alternative to Synthetic Chemicals Drives Industrial Enzymes Market

The report Industrial Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases, Other Types), Source, Application (Food & Beverages, Feed, Bioethanol, Detergents, Pulp & Paper, Textiles & Leather, Wastewater Treatment, Other Applications), Form, and Region - Global Forecast to 2026" According to MarketsandMarkets, the industrial enzymes market is estimated to be valued at USD 5.9 billion in 2020 and is projected to reach USD 8.7 billion by 2026, recording a CAGR of 6.5%, in terms of value. The growing environmental concerns and enzyme quality in food & beverages and feed, and the rising demand for bioethanol are factors that are projected to drive the growth of the industrial enzymes market globally.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=237327836

The microorganism segment is projected to witness significant growth during the forecast period. Based on source, the industrial enzymes market is segmented into microorganism, plant, and animal. The microorganism segment is projected to witness the fastest growth during the forecast period, as enzymes obtained from microbial sources lead to low production costs. Furthermore, they contain more predictable and controllable enzyme content. In addition, as enzymes obtained from microbial sources can be cultured in large quantities in a short period, microorganisms are the primary source of industrial enzymes.

The carbohydrases segment is projected to account for a major share in the industrial enzymes market during the forecast period

By type, the industrial enzymes market is segmented into carbohydrases, proteases, lipases, polymerases & nucleases, and other enzymes (such as catalases, laccases, oxidases, phosphatases, kinases, esterases, and pectinases). Carbohydrases are classified into amylases, cellulases, and other carbohydrases (such as pectinases, lactases, mannanases, and pullulanases). Amylases used in the textile industry benefit denim manufacturers in de-sizing and lowering the operational costs. In the paper industry, amylases help in de-inking and drainage improvement. However, the textile industry functionally benefits in the replacement of pumice stones by a cellulose-based treatment; benefits include less damage to fibers, increased productivity of the machines, and less hazardous environment for manufacturers.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=237327836

The North American region dominated the industrial enzymes market with the largest share in 2019, whereas Asia Pacific is expected to witness the highest growth rate.

The industrial enzymes market in North America was dominant due to the increasing demand for enzymes in industrial applications. Technological innovations in machinery, optimization of production, logistics, and globalization of business have made the food & beverage industry one of the essential sectors in North America. However, the shift of industrial operations from developed regions, such as North America and Europe, to Asia Pacific, has further contributed to the growth of the industrial enzymes market in the Asia Pacific region. The use of industrial enzymes in textiles & leather and detergents has been fueling the market in the Asia Pacific region. Furthermore, European consumers have shown an inclination toward clean-label and organic products. This has enabled manufacturers to consider organic ingredients as major components of the products. Due to this, the industrial enzymes market in the European region is led by the growing focus on the production of food & beverages, owing to the functional benefits of enzymes.

This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as BASF (Germany), Novozymes (Denmark), DuPont (US), DSM (Netherlands), Kerry Group (Ireland), Dyadic International (US), Advanced Enzymes (India), Chr. Hansen (Denmark), Amano Enzymes (Japan), Megazyme (Ireland), Aumgene Biosciences (India), Biocatalysts (UK), Enzyme Supplies (UK), Creative Enzymes (US), Enzyme Solutions (US), Enzymatic Deinking Technologies (US), Sunson Industry Group (China), MetGen (Finland), Denykem (UK), and Tex Biosciences (India).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

Maine Adds PFOS Chemicals to Reporting Requirements for Products for Children

The US state of Maine’s Department of Environmental Protection (DEP) has added perfluorooctane sulfonic acid (PFOS) and its salts to a list of priority chemicals (PCs) that require reporting in specific children’s products.

In addition to PFOS, the salts covered in the new Chapter 890 are:

  • Potassium perfluorooctane sulfonate
  • Lithium perfluorooctane sulfonate
  • Ammonium perfluorooctane sulfonate
  • Diethanolammonium perfluorooctane sulfonate

Maine enacted the ‘Toxic Chemicals in Children’s Products’ law in 2008. It requires manufacturers and/or distributors of children’s products to disclose specific information if a PC is added to a product and exceeds the de minimis level. This requirement does not apply to, among other things, inaccessible components. The list of PCs is evaluated and updated periodically.

‘Children’s product’ is defined as a consumer product that is intended for, made for, or marketed for use by a child under 12 years of age. It also includes any consumer product that contains a chemical of high concern (CHC) that when used or disposed of will likely result in a child under 12 years of age or a fetus being exposed to that chemical.   

Chapter 890 is just the latest rule chapter to be issued. Products included under its scope include:

  • Childcare articles
  • Clothing, footwear, sleepwear
  • Cookware, tableware, reusable food, and beverage containers
  • Cosmetics and personal care products
  • Craft supplies
  • Electronic devices
  • Household furniture and furnishings
  • Toys

Exemptions include:

  • Used products
  • Containers or packaging for food or beverage products, unless they are marketed or intended for use by children under three years of age
  • Motor vehicles or watercrafts, except detachable car seats

The new rule came into effect on July 28, 2020 and the deadline for reporting is January 24, 2021 (180 days from the effective date). Manufacturers or distributors of products under the scope of the chapter, but which are not offered for sale until after January 24, 2021, are obliged to report to the DEP within 30 days.

 Since 2011, other rule chapters that have been issued include:

  • Chapter 882: Bisphenol A (BPA)
  • Chapter 883: Nonylphenols and nonylphenol ethoxylates (NPs and NPEOs)
  • Chapter 884: Cadmium
  • Chapter 885: Formaldehyde
  • Chapter 886: Mercury
  • Chapter 887: Arsenic
  • Chapter 888: Benzylbutyl phthalate (BBP), dibutyl phthalate (DBP), diethyl phthalate (DEP) and di-(2-ethylhexyl) phthalate (DEHP)
  • Chapter 889: Decabromodiphenyl ether (Deca-BDE) and hexabromocyclododecane (HBCD/HBCDD)

 

Toy & Juvenile Product Services

SGS offers a wide range of services to ensure that products comply with relevant standards for juvenile products and childcare articles. They provide consulting, training, product development, testing, audit, and inspection services to ensure that products comply with strict regulations worldwide, demonstrating the safety and quality of juvenile products being brought to the market. Learn more about SGS’s Toy & Juvenile Product Services. 

SGS SafeGuardS keep you up to date with the latest news and developments in the consumer goods industry. Read the full Maine, USA, Designates PFOS Chemicals for Reporting in Children’s Products SafeGuardS. 

Subscribe here to receive SGS SafeGuardS direct to your inbox.

For further information contact:

Hingwo Tsang

Global Information and Innovation Manager

Tel:(+852) 2774 7420

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Website: www.sgs.com/hardlines

LinkedIn: sgs-consumer-goods-&-retail

About SGS

SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 89,000 employees, SGS operates a network of over 2,600 offices and laboratories around the world.​

US Capital Global Increases Its Presence in London with New Office Led by Managing Director Roger Allen

Leading private financial group for the middle market appoints UK-based Managing Director to head-up the firm’s London Office.

Brighton, Brighton and Hove, United Kingdom., August 8, 2020 -- US Capital Global is pleased to announce its increased presence in London and the appointment of Roger Allen as Managing Director of the firm’s new London Office, located in the heart of the City.

Headquartered in San Francisco, US Capital Global operates worldwide with a strong presence in San Francisco, Las Vegas, and London. The group provides sophisticated debt, equity, and investment products to middle market companies and investors, using the latest FinTech and RegTech innovation. Regulatory hosting and compliance services in the UK are provided for the group by Strata Global Limited.

With close to 40 years’ experience within the financial markets, including nine years in asset management, Mr. Allen leads US Capital Global’s London Office with a strong background in FinTech, RegTech, real estate, alternatives, and medical investment sectors. He has a firm appreciation of ESG and impact investing and is focused on connecting investors and financial allocators to expert fund managers and entrepreneurs with a compelling edge, specialising in niche strategies and innovative projects.

“I’m truly grateful to be augmenting US Capital Global as its UK Managing Director,” said Mr. Allen. “Over the past few years, US Capital Global has steadily increased its presence in London, frequently hosting events with The Fintech Times and Security Tokens Realised, and working with some very exciting UK and Europe-based companies. These include Smart Matrix, the British next-generation wound-care company; Takeout Group in Denmark, the socially conscious SaaS food delivery experts; and the pioneering Norwegian green tech real estate firm, MIRIS. I look forward nurturing US Capital Global’s partnerships with our existing British and European clients, while also establishing new mutually-supportive relations with innovative businesses on this side of the Atlantic.”

“Global studies show a significant rise in UK FinTech start-ups,” said Jeffrey Sweeney, Chairman and CEO at US Capital Global. “In 2019 the UK set a new record for FinTech investment by raising over $4.9 billion, which equates to over half of the $8.5 billion European total. US Capital Global continues to be an active agent on this exciting frontier, and we are keen to expand our presence in London and foster new relationships with innovative partners in the UK and Europe. Roger has ample experience in socially conscious business acceleration, and we are thrilled to welcome him onboard and have him at the helm of our growing London Office. We invite all interested parties to connect with us, to learn more about our products and services.”

About US Capital Global:
Established in 1998, US Capital Global leverages the latest FinTech and RegTech innovation to provide sophisticated debt, equity, and investment products to lower middle market companies and investors. The US Capital Global group manages direct investment funds and provides wealth management and capital raise services through its affiliates, including US Capital Global Investment Management LLC, US Capital Global Wealth Management LLC, and its FINRA-registered broker-dealer, US Capital Global Securities LLC. The group collaborates closely with its peers in professional banking and investment advisory. www.uscapglobal.com

To learn more about US Capital Global in the UK and Europe, email Roger Allen, UK Managing Director, at This email address is being protected from spambots. You need JavaScript enabled to view it.

Contact:
Vanessa Guajardo
US Capital Global
555 Montgomery Street, Suite 1501
San Francisco, CA 94111
415-889-1010
This email address is being protected from spambots. You need JavaScript enabled to view it.
https://www.uscapglobal.com

LaTribuna Christian Publishing Reports on the Need for a Safe Pathway to Visitation in American Healthcare

Phoenix, AZ, Aug 11, 2020 -- LaTribuna Christian Publishing’s CEO Chaplain Paul Vescio was quoted saying, “To love and to be loved is part of the human condition in order to maintain a healthy life. Love is the key to maintaining a positive attitude and good mental health and love is the Spiritual medicine we all need especially when having to deal with health issues. Sadly, most patients in American healthcare facilities are being separated, isolated, and medicated even in some cases to the point of losing their mental state. Clearly a safe, compassionate, fair pathway to visitation should have been established by now.”

Chaplain Paul was also quoted saying, “America’s elected officials have got to have a complete change of heart and sit down with America’s healthcare providers and create a safe, fair, and compassionate pathway to visitation. One that allows at least one healthy, screened, family member who takes the same precautions as staff to come in and visit bedside with their loved ones for at least two hours a day for at least two days a week. Members of the Clergy could take the same precautions as well. A visitation program like this is not too much to ask for. A program like this would be allowed for the patients who are in most need of a visit by their family members. Patients who are not as in need of in person visits are still able to face time their loved ones on devices like their cell phones, i-Pads or laptop etc. Patients need the love of family; love helps in our recovery and love holds the answer to the prayers of millions of poor suffering people across our nation right now.”

The following was written in a report by The National Institute of Aging in 2019 about the harmful effects of isolation and loneliness.

Research has linked social isolation and loneliness to higher risks for a variety of physical and mental conditions: high blood pressure, heart disease, obesity, a weakened immune system, anxiety, depression, cognitive decline, Alzheimer’s disease, and even death.

People who find themselves unexpectedly alone due to the death of a spouse or partner, separation from friends or family, retirement, loss of mobility, and lack of transportation are at particular risk.

Conversely, people who engage in meaningful, productive activities with others tend to live longer, boost their mood, and have a sense of purpose. These activities seem to help maintain their well-being and may improve their cognitive function, studies show.

Losing a sense of connection and community changes a person’s perception of the world. Someone experiencing chronic loneliness feels threatened and mistrustful of others, which activates a biological defense mechanism, according to Steve Cole, Ph.D., director of the Social Genomics Core Laboratory at the University of California, Los Angeles. His NIA-funded research focuses on understanding the physiological pathways of loneliness (the different ways that loneliness affects how your mind and body function) and developing social and psychological interventions to combat it.

Dr. Cole said, “For example, loneliness may alter the tendency of cells in the immune system to promote inflammation, which is necessary to help our bodies heal from injury. But inflammation that lasts too long increases the risk of chronic diseases.”

“Dr Cole said, “Loneliness acts as a fertilizer for other diseases.” Dr. Cole also said. “The biology of loneliness can accelerate the buildup of plaque in arteries, help cancer cells grow and spread, and promote inflammation in the brain leading to Alzheimer’s disease. Loneliness promotes several different types of wear and tear on the body.”

Dr. Cole also said, “People who feel lonely may also have weakened immune cells that have trouble fighting off viruses, which makes them more vulnerable to some infectious diseases.”

The NIA also said, “NIA-supported research by Dr. Cole and others shows that having a sense of mission and purpose in life is linked to healthier immune cells. Helping others through caregiving or volunteering also helps people feel less lonely.”

https://www.nia.nih.gov/news/social-isolation-loneliness-older-people-pose-health-risks

LaTribuna Christian Publishing’s CEO Chaplain Paul Vescio was also quoted saying, “The Bible teaches us that we are to love thy neighbor as thy self and to treat others as we ourselves would want to be treated. We all want to be loved, we all want to be treated with kindness, respect and compassion. Providing a safe, fair, compassionate pathway to visitation in American healthcare is in itself an act of kindness, compassion and love for all those who are all alone and suffering each day.”

LaTribuna Christian Publishing supports acts of kindness and compassion towards others for more information please visit their websites.

LaTribuna Christian Publishing CEO Chaplain Paul Vescio
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.miraclesofkingman.com
www.latribunachristianpublishing316.com

DIGI BROKING Launched in India for Seamless Cryptocurrency Trading

New Delhi, India: Today, DIGI BROKING, a coin trading platform in India is launched, where traders and investors of all levels have the freedom to buy, sell, or trade all mainstream cryptocurrencies in INR using their credit cards, debit cards, UPI, wallets, and net banking. The Indian users can now trade 50+ coin pairs on this platform with a zero deposit & withdrawal fee. 

 

Being the trading member of world’s largest cryptocurrency exchange in terms of trading members PCEX, DIGI BROKING claims to offer the best crypto trading experience to beginners and seasoned traders alike by offering liquidity, multiple market options, payment options, lowest trading fees, separate trading and funding wallets, along with 24/7 instant support services. 

 

Now, Indian users can buy, sell, or trade mainstream cryptocurrencies like BTC, LTC, BCH, DASH, XMR, etc in the INR, USD, USDT, and C2USD market at the lowest trading fees. Moreover, now users can trade, deposit, and withdraw in INR for free. 

 

We are in the business of simplifying crypto trading for investors or traders of all levels, said Mr. Jai Phogat, CEO and Founder at DIGI BROKING. He further said that, at DIGI BROKING they aim to give traders and investors a new investment opportunity to grow and make an investment in the crypto universe with better understanding and reliability. For us, the success of our platform depends on how successful our users become in the crypto universe,” he added. 

 

What’s for traders and investors on DIGI BROKING: 

 

  • Seamless registration process
  • User-friendly interference
  • Access to 50+ coin pairs
  • Multiple market options
  • Multiple [payment options
  • Lowest trading fees
  • Zero Deposit & Withdrawal fees
  • Separate trading wallet and funding wallet

 

The platform is also best for those looking for profitable business opportunities in the crypto universe. DIGI BROKING also comes with a unique B2B Franchise Model, inviting businesses and individuals to start their own crypto business as Master Franchise, Franchise, or Freelancer and enjoy up to 80% revenue share by creating their own chain of clients. To know more about the business model, click here (redirect to DIGI Broking business model page)

 

About DIGI BROKING  

 

Founded by JVM Enterprises, DIGI BROKING is one of the coin trading platforms in India that enables traders and investors to buy, sell, or trade all mainstream cryptocurrencies in INR directly using their bank accounts, credit cards, debit cards, UPI, and wallets. It is also one of the crypto trading platforms in India that help businesses and individuals alike to start their own trading business as Master Franchise, Franchise, and Freelancer by creating a chain of clients and leveraging the benefits of DIGI BROKING network, volume, and liquidity. To learn more about DIGI Broking, visit www.digibroking.com.